Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat(®) fixed-dose combination for chronic obstructive pulmonary dis...

por Selya-Hammer, Carl, Gonzalez-Rojas Guix, Nuria, Baldwin, Michael, Ternouth, Andrew, Miravitlles, Marc, Rutten-van Mölken, Maureen, Goosens, Lucas M.A., Buyukkaramikli, Nasuh, Acciai, Valentina
Publicado 2016